Literature DB >> 9606525

Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task.

D Servan-Schreiber1, C S Carter, R M Bruno, J D Cohen.   

Abstract

BACKGROUND: A neural network computer model described in a companion paper predicted the effects of increased dopamine transmission on selective attention under two different hypotheses.
METHODS: To evaluate these predictions we conducted an empirical study in human subjects of D-amphetamine effects on performance of the Eriksen response competition task. Ten healthy volunteers were tested before and after placebo or D-amphetamine in a double-blind cross-over design.
RESULTS: D-amphetamine induced a speeding of reaction time overall and an improvement of accuracy at fast reaction times but only in the task condition requiring selective attention.
CONCLUSIONS: This pattern of results conforms to the prediction of the model under the hypothesis that D-amphetamine primarily affects dopamine transmission in cognitive rather than motor networks. This suggests that the principles embodied in parallel distributed processing models of task performance may be sufficient to predict and explain specific behavioral effects of some drug actions in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606525     DOI: 10.1016/s0006-3223(97)00449-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

1.  Perceptual decisions formed by accumulation of audiovisual evidence in prefrontal cortex.

Authors:  Uta Noppeney; Dirk Ostwald; Sebastian Werner
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  A neural network model of the Eriksen task: reduction, analysis, and data fitting.

Authors:  Yuan Sophie Liu; Philip Holmes; Jonathan D Cohen
Journal:  Neural Comput       Date:  2008-02       Impact factor: 2.026

3.  Task-load-dependent activation of dopaminergic midbrain areas in the absence of reward.

Authors:  Carsten N Boehler; Jens-Max Hopf; Ruth M Krebs; Christian M Stoppel; Mircea A Schoenfeld; Hans-Jochen Heinze; Toemme Noesselt
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

4.  Amphetamine modulates brain signal variability and working memory in younger and older adults.

Authors:  Douglas D Garrett; Irene E Nagel; Claudia Preuschhof; Agnieszka Z Burzynska; Janina Marchner; Steffen Wiegert; Gerhard J Jungehülsing; Lars Nyberg; Arno Villringer; Shu-Chen Li; Hauke R Heekeren; Lars Bäckman; Ulman Lindenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-01       Impact factor: 11.205

5.  Amphetamine Exerts Dose-Dependent Changes in Prefrontal Cortex Attractor Dynamics during Working Memory.

Authors:  Christopher C Lapish; Emili Balaguer-Ballester; Jeremy K Seamans; Anthony G Phillips; Daniel Durstewitz
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

Review 6.  Individual variation in resisting temptation: implications for addiction.

Authors:  Benjamin T Saunders; Terry E Robinson
Journal:  Neurosci Biobehav Rev       Date:  2013-02-21       Impact factor: 8.989

7.  Attentional bias to food images associated with elevated weight and future weight gain: an fMRI study.

Authors:  Sonja Yokum; Janet Ng; Eric Stice
Journal:  Obesity (Silver Spring)       Date:  2011-06-16       Impact factor: 5.002

Review 8.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

9.  Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil.

Authors:  Charles S Peretti; Fabien Gierski; Sophie Harrois
Journal:  Psychopharmacology (Berl)       Date:  2004-05-12       Impact factor: 4.530

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.